Pacific Edge Retail Offering Closing Date Reminder

Pacific Edge would like to remind Eligible Shareholders of the opportunity to subscribe for new ordinary shares in Pacific Edge through the Retail Offer.

The Retail Offer closes at 5.00pm NZDT on Wednesday 13 October 2021

The Offer is part of Pacific Edge's equity raising announced on 23 September 2021 which also included a successful NZ$80 million (A$77.5 million) upsized placement to institutional and other eligible investors (Placement). Pacific Edge is seeking to raise up to a further NZ$20 million (A$19.4 million) by way of the Offer to eligible New Zealand shareholders. However, Pacific Edge can accept oversubscriptions at its absolute discretion.

Participating in the Offer

Eligible Shareholders can participate in the Offer online at https://pacificedge.capitalraise.co.nz. To complete an acceptance online Eligible Shareholders will need their Holder Number and the unique Entitlement Number stated below. Eligible Shareholders should complete their application allowing sufficient time for it to be received by 5.00pm NZDT on Wednesday 13 October 2021.

If you have completed your application recently, you do not have to take any further action.

About the Offer

The Offer will enable all eligible New Zealand shareholders of Pacific Edge Limited to participate in the equity raising and acquire new Shares, with a minimum application amount of NZ$250.00 and a maximum application amount of NZ$50,000.

The issue price per Share will be the lower of NZ$1.35 (being the price paid by investors under the Placement) and the volume weighted average price of Shares over the 5-day trading period before the Closing Date of the Offer (being 13 October 2021, unless extended).

The proceeds of the equity raising will be used to accelerate growth into the company’s key market, the United States (US), to further growth in Southeast Asia, to increase investment in research and development of PEL's current product range (Cxbladder), and also to potentially develop and grow new product opportunities by leveraging intellectual property across other cancers that can be detected in urine. The proceeds of the equity raising will also provide Pacific Edge with additional balance sheet flexibility. Further details about the proposed use of proceeds are set out in the Investor Presentation released by Pacific Edge on 23 September 2021 in connection with the equity raising.

Further details about the Retail Offer are included in the Offer Document which can be viewed online at https://pacificedge.capitalraise.co.nz